Clinical Trial Update: Pharmacokinetics (PK) Study of Once Daily Darunavir/Ritonavir and Twice and Once Daily Raltegravir in HIV-infected Subjects [Phase 1]

View source ↗

Summary

Phase 1 pharmacokinetic study in HIV-infected subjects comparing once-daily darunavir/ritonavir with twice-daily and once-daily raltegravir to characterize expo…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Drugs mentioned

• Isentress (Raltegravir)
• darunavir/ritonavir (darunavir/ritonavir)

Snippet

Sponsor: St Stephens Aids Trust | Conditions: HIV Infections | Phase 1 | Status: COMPLETED